CASI Pharma (CASI) Reports Q2 Loss of $0.06/Share

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.06), versus ($0.06) reported last year. Revenue for the quarter came in at $24 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• GLJ Research rips into SolarEdge Technologies (SEDG): 'We'd be aggressively fading this move'
• Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target